Literature DB >> 2790452

Tumour necrosis factor-alpha and lymphotoxin have opposite effects on sympathetic efferent nerves to brown adipose tissue by direct action in the central nervous system.

S J Holt1, R F Grimble, D A York.   

Abstract

Intracerebral injection of recombinant human tumour necrosis factor-alpha (rTNF alpha) decreased, whereas lymphotoxin increased the activity of the sympathetic efferent nerves to interscapular brown adipose tissue (IBAT). The changes in firing rates were accompanied by a significant dose-dependent change in IBAT and rectal temperatures (which were decreased with rTNF alpha and increased with lymphotoxin treatment). These results indicate that rTNF alpha and lymphotoxin act directly in the CNS to modulate the sympathetic outflow to IBAT. The opposite effects of the two peptides also suggest that in the CNS, separate receptor systems exist.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2790452     DOI: 10.1016/0006-8993(89)90986-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Acute metabolic effects of human recombinant tumor necrosis factor beta in the rat.

Authors:  D Blumberg; A Tsuburaya; M Burt; D B Donner; M F Brennan
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

Review 2.  Influencing Factors of Thermogenic Adipose Tissue Activity.

Authors:  Guoqing Zhang; Qinghua Sun; Cuiqing Liu
Journal:  Front Physiol       Date:  2016-02-05       Impact factor: 4.566

3.  Diacerein decreases TNF-alpha and IL-1beta levels in peritoneal fluid and prevents Baker's yeast-induced fever in young rats.

Authors:  Juliana Saibt Martins Pasin; Ana Paula Oliveira Ferreira; André Luis Lopes Saraiva; Viviane Ratzlaff; Rosália Andrighetto; Jorgete Tomazetti; Daiana Silva Avila; Sydney Hartz Alves; Maribel Antonello Rubin; Juliano Ferreira; Adair Roberto Soares Santos; Carlos Fernando Mello
Journal:  Inflamm Res       Date:  2010-03       Impact factor: 4.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.